Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Escalating, Multiple-dose Study in House Dust Mite Allergic Subjects to Assess the Safety of Intradermal Injection of ToleroMune HDM

NCT01008332 is registered in ClinicalTrials.gov with Circassia Limited as lead sponsor.

NCT NCT01008332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01008332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Escalating, Multiple-dose Study in House Dust Mite Allergic Subjects to Assess the Safety of Intradermal Injection of ToleroMune HDM
Lead sponsor
Circassia Limited
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
August 31, 2010
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy